Page last updated: 2024-08-24

milnacipran and Parkinson Disease

milnacipran has been researched along with Parkinson Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Higuchi, H; Kamata, M; Shimizu, T; Takahashi, H; Yoshida, K	1

Other Studies

1 other study(ies) available for milnacipran and Parkinson Disease

Article	Year
Remarkable effect of milnacipran, a serotonin-noradrenalin reuptake inhibitor (SNRI), on depressive symptoms in patients with Parkinson's disease who have insufficient response to selective serotonin reuptake inhibitors (SSRIs): two case reports. Progress in neuro-psychopharmacology & biological psychiatry, 2005, Volume: 29, Issue:2 Topics: Adrenergic Uptake Inhibitors; Cyclopropanes; Depression; Female; Humans; Male; Middle Aged; Milnacipran; Parkinson Disease; Selective Serotonin Reuptake Inhibitors	2005

Article

Year

Remarkable effect of milnacipran, a serotonin-noradrenalin reuptake inhibitor (SNRI), on depressive symptoms in patients with Parkinson's disease who have insufficient response to selective serotonin reuptake inhibitors (SSRIs): two case reports.

Progress in neuro-psychopharmacology & biological psychiatry, 2005, Volume: 29, Issue:2

Topics: Adrenergic Uptake Inhibitors; Cyclopropanes; Depression; Female; Humans; Male; Middle Aged; Milnacipran; Parkinson Disease; Selective Serotonin Reuptake Inhibitors

2005